Brighter Together
Performance
2021 was a year of growth and resilience for Hilton. We opened more than one hotel per day, celebrated numerous brand milestones and saw first-time entries into new global markets, all while spreading the light and warmth of hospitality around the world. With more than 2,600 additional hotels in the pipeline, the future is bright.
Guest Experience
By combining innovative new offerings with Hilton’s reliable and friendly service, we’ve enhanced our guests' experiences so they can focus on what really matters — creating new memories.
Our Team Members are at the heart of who we are and what we do. As we work together to create heartfelt, memorable experiences for our guests, we are also ensuring that Hilton is an inclusive place to build a rewarding career.
A Message from Chris Nassetta
It’s never been clearer that Hilton is an engine of opportunity and a beacon of hope for all our stakeholders. Our Team Members’ continued resilience and innovation in the face of a changing pandemic ensured that we remained focused on the future, energized by the belief that we shine brighter together.”
Chris Nassetta President & CEO
A Message from Kevin Jacobs
We’re proud of the financial flexibility we demonstrated through the pandemic and remain confident in our balance sheet management and ability to continue to be an engine of growth and opportunity for our owners, Team Members, shareholders and partners.”
Kevin Jacobs Chief Financial Officer & President, Global Development
- Today's news
- Reviews and deals
- Climate change
- 2024 election
- Fall allergies
- Health news
- Mental health
- Sexual health
- Family health
- So mini ways
- Unapologetically
- Buying guides
Entertainment
- How to Watch
- My Portfolio
- Latest News
- Stock Market
- Biden Economy
- Stocks: Most Actives
- Stocks: Gainers
- Stocks: Losers
- Trending Tickers
- World Indices
- US Treasury Bonds Rates
- Top Mutual Funds
- Options: Highest Open Interest
- Options: Highest Implied Volatility
- Basic Materials
- Communication Services
- Consumer Cyclical
- Consumer Defensive
- Financial Services
- Industrials
- Real Estate
- Stock Comparison
- Advanced Chart
- Currency Converter
- Credit Cards
- Balance Transfer Cards
- Cash-back Cards
- Rewards Cards
- Travel Cards
- Credit Card Offers
- Best Free Checking
- Student Loans
- Personal Loans
- Car insurance
- Mortgage Refinancing
- Mortgage Calculator
- Morning Brief
- Market Domination
- Market Domination Overtime
- Asking for a Trend
- Opening Bid
- Stocks in Translation
- Lead This Way
- Good Buy or Goodbye?
- Financial Freestyle
- Capitol Gains
- Living Not So Fabulously
- Decoding Retirement
- Fantasy football
- Pro Pick 'Em
- College Pick 'Em
- Fantasy baseball
- Fantasy hockey
- Fantasy basketball
- Download the app
- Daily fantasy
- Scores and schedules
- GameChannel
- World Baseball Classic
- Premier League
- CONCACAF League
- Champions League
- Motorsports
- Horse racing
- Newsletters
New on Yahoo
- Privacy Dashboard
Yahoo Finance
Capricor therapeutics to present at upcoming investor and scientific conferences.
SAN DIEGO, Sept. 06, 2024 (GLOBE NEWSWIRE) -- Capricor Therapeutics (NASDAQ: CAPR), a biotechnology company developing transformative cell and exosome-based therapeutics for the treatment of rare diseases, today announced that the Company is scheduled to present at various upcoming investor and scientific conferences.
| (New York, NY) |
| September 9, 2024 at 2:00 p.m. ET |
| Company presentation and one-on-one meetings |
|
|
| (Boston, MA) |
| September 17-19, 2024 |
| Company presentation and industry panel |
| (New York, NY) |
| September 18, 2024 at 8:35 a.m. ET |
| Fireside chat and one-on-one meetings |
|
|
Capricor management will present updates on Capricor’s recent progress on its lead program of deramiocel for the treatment of Duchenne muscular dystrophy (DMD) as well as other general scientific and corporate updates. For more information on these presentations, please visit Capricor's website at http://capricor.com/news/events/ .
About Capricor Therapeutics
Capricor Therapeutics, Inc. (NASDAQ: CAPR) is a biotechnology company dedicated to advancing transformative cell and exosome-based therapeutics to redefine the treatment landscape for rare diseases. At the forefront of our innovation is our lead product candidate, deramiocel (CAP-1002), an allogeneic cardiac-derived cell therapy. Extensive preclinical and clinical studies have shown deramiocel to demonstrate immunomodulatory, antifibrotic, and regenerative actions specifically tailored for dystrophinopathies and heart disease. Deramiocel is currently advancing through Phase 3 clinical development for the treatment of Duchenne muscular dystrophy. Capricor is also harnessing the power of its exosome technology, using its proprietary StealthX™ platform in preclinical development focused on the areas of vaccinology, targeted delivery of oligonucleotides, proteins and small molecule therapeutics to potentially treat and prevent a diverse array of diseases. At Capricor, we stand committed to pushing the boundaries of possibility and forging a path toward transformative treatments for those in need. For more information, visit capricor.com , and follow Capricor on Facebook , Instagram and Twitter .
Cautionary Note Regarding Forward-Looking Statements
Statements in this press release regarding the efficacy, safety, and intended utilization of Capricor’s product candidates; the initiation, conduct, size, timing and results of discovery efforts and clinical trials; the pace of enrollment of clinical trials; plans regarding regulatory filings, future research and clinical trials; regulatory developments involving products, including the ability to obtain regulatory approvals or otherwise bring products to market; manufacturing capabilities; dates for regulatory meetings; statements about our financial outlook; the ability to achieve product milestones and to receive milestone payments from commercial partners; plans regarding current and future collaborative activities and the ownership of commercial rights; scope, duration, validity and enforceability of intellectual property rights; future revenue streams and projections; expectations with respect to the expected use of proceeds from the recently completed offerings and the anticipated effects of the offerings; and any other statements about Capricor’s management team’s future expectations, beliefs, goals, plans or prospects constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Any statements that are not statements of historical fact (including statements containing the words “believes,” “plans,” “could,” “anticipates,” “expects,” “estimates,” “should,” “target,” “will,” “would” and similar expressions) should also be considered to be forward-looking statements. There are a number of important factors that could cause actual results or events to differ materially from those indicated by such forward-looking statements. More information about these and other risks that may impact Capricor’s business is set forth in Capricor’s Annual Report on Form 10-K for the year ended December 31, 2023, as filed with the Securities and Exchange Commission on March 11, 2024, and in our Quarterly Report on Form 10-Q for the quarter ended June 30, 2024, as filed with the Securities and Exchange Commission on August 8, 2024. All forward-looking statements in this press release are based on information available to Capricor as of the date hereof, and Capricor assumes no obligation to update these forward-looking statements.
Capricor has entered into an agreement for the exclusive commercialization and distribution of deramiocel ( CAP-1002) for DMD in the United States and Japan with Nippon Shinyaku Co., Ltd. (U.S. subsidiary: NS Pharma , Inc.), subject to regulatory approval. Deramiocel is an Investigational New Drug and is not approved for any indications. None of Capricor’s exosome-based candidates have been approved for clinical investigation.
For more information, please contact:
Capricor Media Contact: Raquel Cona KCSA Strategic Communications [email protected] 212.896.1204
Capricor Company Contact: AJ Bergmann, Chief Financial Officer [email protected] 858.727.1755
- Market data
- Connectivity
- News and events
- Investor Relations
Connect to MOEX products for business
Presentations.
- Financial statements
- Annual reports
- Reporting and presentations
- 2Q 2024 Earnings presentation
- 1Q 2024 Earnings presentation
- 4Q 2023 Earnings presentation
- 3Q 2023 Earnings presentation
- MOEX Strategy 2028 webcast transcript
- Webcast recording on MOEX Strategy 2028
- 2Q 2023 Earnings presentation
- 1Q 2023 Earnings presentation
- 4Q 2022 Earnings presentation
- 3Q 2022 Earnings presentation
- 2Q 2022 Earnings presentation
- Investor presentation, March 2022
- Investor presentation, February 2022
- Investor presentation, January 2022
- Investor presentation, December 2021
- Investor presentation, November 2021
- Investor presentation, October 2021
- Investor presentation, September 2021
- MOEX Global Business: Equities Breakthrough
- Investor presentation, August 2021
- Investor presentation, July 2021
- Investor presentation, June 2021
- Investor presentation, May 2021
- Investor presentation, April 2021
- Investor presentation, March 2021
- Investor presentation, February 2021
- Marketplace (Finuslugi.ru) update
- Investor presentation, January 2021
- Investor presentation, December 2020
- Investor presentation, November 2020
- Investor presentation, October 2020
- Investor presentation, September 2020
- Investor presentation, August 2020
- Investor presentation, July 2020
- Investor presentation, June 2020
- Investor presentation, May 2020
- Investor presentation, April 2020
- Investor presentation, March 2020
- Investor presentation, February 2020
- Investor presentation, January 2020
- Investor presentation, December 2019
- Investor presentation, November 2019
- Moscow Exchange Group’s Strategy 2024
- Investor presentation, October 2019
- Investor presentation, September 2019
- Investor presentation, August 2019
- Investor presentation, July 2019
- Investor presentation, June 2019
- Investor presentation, May 2019
- Investor presentation, April 2019
- Investor presentation, March 2019
- Investor presentation, February 2019
- Investor presentation, January 2019
- Investor presentation, December 2018
- Investor presentation, November 2018
- Investor presentation, October 2018
- Investor presentation, September 2018
- Investor presentation, August 2018
- Investor presentation, July 2018
- Investor presentation, June 2018
- Investor presentation, May 2018
- Investor presentation, April 2018
- Investor presentation, March 2018
- Investor presentation, February 2018
- Investor presentation, January 2018
- Investor presentation, December 2017
- Investor presentation, November 2017
- Investor presentation, October 2017
- Investor presentation, September 2017
- Investor presentation, August 2017
- Investor presentation, July 2017
- Investor presentation, June 2017
- Investor presentation, May 2017
- Investor presentation, April 2017
- Investor presentation, March 2017
- Investor presentation, February 2017
- Investor presentation, January 2017
- Investor presentation, December 2016
- Investor presentation, November 2016
- Investor presentation, October 2016
- Investor presentation, September 2016
- Investor presentation, August 2016
- Investor presentation, July 2016
- Investor presentation, June 2016
- Investor presentation, May 2016
- Investor presentation, April 2016
- Investor presentation, March 2016
- Investor presentation, February 2016
- Investor presentation, January 2016
- Investor presentation, December 2015
- Investor presentation, November 2015
- Investor presentation, October 2015
- Investor presentation, September 2015
- Investor presentation, August 2015
- Investor presentation, July 2015
- Investor presentation, June 2015
- Investor presentation, May 2015
- Investor presentation, April 2015
- Investor presentation, March 2015
- Deutsche Bank dbAccess CEEMEA Conference (Jan 21-23)
- Investor presentation, December 2014 (pdf, 1 Mb)
- Investor presentation, November 2014 (pdf, 1 Mb)
- Investor presentation, October 2014 (pdf, 1 Mb)
- Investor presentation, August 2014 (pdf, 1 Mb)
- Investor presentation, July 2014 (pdf, 1 Mb)
- Investor conference Renaissance Capital, 23-25 June (pdf, 930 Kb)
- Investor presentation (May) (pdf, 1 Mb)
- Business breakfast: Analyst day, April 2014 (pdf, 1 Mb)
- Non-deal road-show presentation, March 31-April 9, 2014 (pdf, 1 Mb)
- Investor presentation, February 2014 (pdf, 739 Kb)
- Investor presentation, December 2013 (pdf, 750 Kb)
- Investor presentation, November 2013 (pdf, 800 Kb)
- Non-deal road show presentation, September 24-30, 2013 (pdf, 690 Kb)
- Investor presentation, August 2013 (pdf, 1 Mb)
- Investor presentation, July 2013 (pdf, 970 Kb)
- Investor presentation, June 2013 (pdf, 1 Mb)
- Investor presentation, April 2013 (pdf, 900 Kb)
- Investor presentation, December 2018 (pdf, 1 Mb)
- Investor presentation, November 2018 (pdf, 1 Mb)
- Investor presentation, October 2018 (pdf, 1 Mb)
- Investor presentation, September 2018 (pdf, 1 Mb)
- Investor presentation, August 2018 (pdf, 1 Mb)
- Investor presentation, July 2018 (pdf, 1 Mb)
- Investor presentation, June 2018 (pdf, 1 Mb)
- Investor presentation, May 2018 (pdf, 1 Mb)
- Investor presentation, April 2018 (pdf, 1 Mb)
- Investor presentation, March 2018 (pdf, 1 Mb)
- Investor presentation, February 2018 (pdf, 1 Mb)
- Investor presentation, January 2018 (pdf, 1 Mb)
- Investor presentation, December 2017 (pdf, 1 Mb)
- Investor presentation, November 2017 (pdf, 1 Mb)
- Investor presentation, October 2017 (pdf, 1 Mb)
- Investor presentation, September 2017 (pdf, 1 Mb)
- Investor presentation, August 2017 (pdf, 1 Mb)
- Investor presentation, July 2017 (pdf, 1 Mb)
- Investor presentation, June 2017 (pdf, 1 Mb)
- Investor presentation, May 2017 (pdf, 1 Mb)
- Investor presentation, April 2017 (pdf, 1 Mb)
- Investor presentation, March 2017 (pdf, 1 Mb)
- Investor presentation, February 2017 (pdf, 1 Mb)
- Investor presentation, January 2017 (pdf, 1 Mb)
- Investor presentation, December 2016 (pdf, 1 Mb)
- Investor presentation, November 2016 (pdf, 1 Mb)
- Investor presentation, October 2016 (pdf, 1 Mb)
- Investor presentation, September 2016 (pdf, 1 Mb)
- Investor presentation, August 2016 (pdf, 1 Mb)
- Investor presentation, July 2016 (pdf, 1 Mb)
- Investor presentation, June 2016 (pdf, 930 Kb)
- Investor presentation, May 2016 (pdf, 1 Mb)
- Investor presentation, April 2016 (pdf, 1 Mb)
- Investor presentation, March 2016 (pdf, 1 Mb)
- Investor presentation, February 2016 (pdf, 1 Mb)
- Investor presentation, January 2016 (pdf, 1 Mb)
- Investor presentation, December 2015 (pdf, 1 Mb)
- Investor presentation, November 2015 (pdf, 1 Mb)
- Investor presentation, October 2015 (pdf, 1 Mb)
- Investor presentation, September 2015 (pdf, 1 Mb)
- Investor presentation, August 2015 (pdf, 1 Mb)
- Investor presentation, July 2015 (pdf, 1 Mb)
- Investor presentation, June 2015 (pdf, 1 Mb)
- Investor presentation, May 2015 (pdf, 1 Mb)
- Investor presentation, April 2015 (pdf, 1 Mb)
- Investor presentation, March 2015 (pdf, 1 Mb)
- Deutsche Bank dbAccess CEEMEA Conference (Jan 21-23) (pdf, 739 Kb)
2021 Investment Banking Off-cycle Internship (Moscow)
Placement and duration
The Investment Banking Off-cycle Internship is an opportunity to experience the culture and atmosphere in the Investment Banking Division (IBD) by taking on some of the responsibilities and functions of a Full-time Analyst for a short period. The internship typically lasts three to six months, but can vary in length depending on business needs and candidate availability. You will spend your internship assigned to a specific group in a specific region, building basic skills in financial analysis, accounting and valuation, while working on a wide range of domestic and international transactions.
Training program
You will receive on-the-job training and benefit from working alongside experienced professionals on a variety of projects.
Responsibilities
Gathering and synthesising financial and operating information about companies, industries and governments.
Creating and updating financial models.
Gathering market data to analyse trends and help value and price transactions.
Drafting presentations and memoranda for a wider audience within the Firm and the financial services industry.
Attending team discussions and client meetings, where you may be asked to deliver parts of a presentation.
Qualifications/ Skills/ Requirements
You have strong analytical and numerical skills that put You at ease with financial data.
You are results-driven, and perform well under pressure and against tight deadlines.
You are a proven team player and can manage a wide range of responsibilities.
You have an excellent academic background and fluency in English.
Ability to communicate effectively in multiple languages is an advantage.
You articulate complex ideas simply and summarise them effectively.
You are committed to excellence in your work and maintain high professional and ethical standards.
*Salary is competitive with excellent benefits.
This Program is closed to applications.
IMAGES
COMMENTS
Event. October 27, 2021. Q3 2021 Earnings Conference Call. July 29, 2021. Q2 2021 Earnings Conference Call. May 05, 2021. Q1 2021 Earnings Conference Call. February 17, 2021. Q4 2020 Earnings Conference Call.
November 2021. Presentation. • Award-winning brands that serve guests for virtually any lodging need they have anywhere in the world • Leads to satisfied customers, including 123 million Hilton Honors loyalty members • Creates a network effect that drives a strong global RevPAR premium of 16%(a) • These premiums drive strong financial ...
Hilton - Investor Relations
Hilton (NYSE: HLT) is a leading global hospitality company with a portfolio of 24 world-class brands comprising more than 8,000 properties and more than 1.2 million rooms, in 126 countries and territories. Dedicated to fulfilling its founding vision to fill the earth with the light and warmth of hospitality, Hilton has welcomed over 3 billion guests in its more than 100-year history, was named ...
Date Document Download; February 16, 2022 Q4 2021 Earnings Release February 16, 2022
Highlights include: Diluted EPS was $0.52 for the fourth quarter and $1.46 for the full year, and diluted EPS, adjusted for special items, was $0.72 for the fourth quarter and $2.08 for the full ...
MCLEAN, Va. - Hilton Worldwide Holdings Inc. ("Hilton" or the "Company") (NYSE: HLT) today reported its fourth quarter and full year 2021 results. The following results reflect the material impact that the coronavirus ("COVID-19") pandemic has had on Hilton's business. Highlights include: Diluted EPS was $0.52 for the fourth quarter and $1.46 ...
Investor Contact 7930 Jones Branch Drive Jill Slattery McLean, VA 22102 +1 703 883 6043 ir.hilton.com Media Contact Megan Ryan +1 703 883 6711 Hilton Reports Second Quarter Results MCLEAN, VA (July 29, 2021) - Hilton Worldwide Holdings Inc. ("Hilton" or the "Company") (NYSE: HLT) today reported its second quarter 2021 results.
Investor Contact 7930 Jones Branch Drive Jill Slattery McLean, VA 22102 +1 703 883 6043 ir.hilton.com Media Contact Nigel Glennie +1 703 883 5262 Hilton Reports First Quarter Results MCLEAN, VA (May 5, 2021) - Hilton Worldwide Holdings Inc. ("Hilton" or the "Company") (NYSE: HLT) today reported its first quarter 2021 results.
(b) Also includes Hilton's newest brand with the working title Project H3, which is not pictured above. (c) For the LTM 9/30/2023. Adj. EBITDA is a non-GAAP financial measure. Please refer to the Appendix of this presentation for important information about non-GAAP financial measures and for the reconciliations of the non-GAAP financial measures
ag 4. 2021 was a year of growth and resilience for Hilton. We opened more than hotel per day, celebrated numerous milestones and saw first-time entries new global markets, all while spreading light and warmth of hospitality around world. With more than 2,600 additional hotels in the pipeline, the future is.
Events & Presentations
Quarterly Results 2023
Performance. 2021 was a year of growth and resilience for Hilton. We opened more than one hotel per day, celebrated numerous brand milestones and saw first-time entries into new global markets, all while spreading the light and warmth of hospitality around the world. With more than 2,600 additional hotels in the pipeline, the future is bright.
Third Quarter 2022. System-wide comparable RevPAR, on a currency neutral basis, is expected to increase between 25.0 percent and 30.0 percent compared to the third quarter of 2021, and to increase between 1.0 percent and 5.0 percent from the third quarter of 2019. Diluted EPS is projected to be between $1.09 and $1.16.
Hilton
Investors. Our ambition is to be the International food and supply chain services partner of choice. ... 2021; 2020; 2019; Archive; 04/09/2024. ... View online PDF download 120.4KB. 04/09/2024. Hilton Foods Interim Results Presentation 2024. View online PDF download 9.0MB. 04/09/2024. Hilton Foods Interim Results Presentation Recording 2024 ...
Investor Contact 7930 Jones Branch Drive Brian Kucaj McLean, VA 22102 +1 703 883 5476 ir.hilton.com Media Contact Kent Landers +1 703 883 3246 Hilton Reports First Quarter Results; Raises Full Year Outlook MCLEAN, VA (April 26, 2023) - Hilton Worldwide Holdings Inc. ("Hilton" or the "Company") (NYSE: HLT) today reported its first quarter 2023 ...
MCLEAN, Va. - Hilton Worldwide Holdings Inc. ("Hilton" or the "Company") (NYSE: HLT) today reported its first quarter 2021 results. The following results reflect the material impact that the novel coronavirus ("COVID-19") pandemic has had on Hilton's business. Highlights include: Diluted EPS was $ (0.39) for the first quarter, and diluted EPS ...
All Hilton Foods retail packaging fully reusable, recyclable or compostable by 2025 Halve Hilton Foods factory generated food waste by 2030 compared to 2019 Weighting Maximum vesting Scope 1 & 2 energy efficiency 5% 43.9% reduction over 3 years Packaging recycled content 5% 28.3% increase over 3 years Food waste 5% 30.0% reduction over 3 years ...
U.S. 73% Europe 11% Asia Pacific 10% Americas Non-U.S. 3% Middle East & Africa 3 Industry-leading, clearly defined, global brands drive a 15% global RevPAR premium(a) Luxury & Lifestyle Full Service All Suites Focused Service Timeshare
Presentation Details: Virtual presentation accessible online to conference attendees on the morning of Monday, September 9, 2024 . 2024 Cantor Global Healthcare Conference. Date: September 17-19, 2024
The presentation can be found on the Investor Relations section of the Company's website u. NASHVILLE, Tenn., Sept. 09, 2024 (GLOBE NEWSWIRE) -- Ryman Hospitality Properties, Inc. (NYSE: RHP ...
Event:H.C. Wainwright 26th Annual Global Investment Conference (New York, NY)Presentation:September 9, 2024 at 2:00 p.m. ETFormat:Company presentation and one-on-one meetings Event
4Q 2023 Earnings presentation 3Q 2023 Earnings presentation MOEX Strategy 2028 webcast transcript Webcast recording on MOEX Strategy 2028 2Q 2023 Earnings presentation 1Q 2023 Earnings presentation 4Q 2022 Earnings presentation 3Q 2022 Earnings presentation 2Q 2022 Earnings presentation Investor presentation, March 2022 Investor presentation, February 2022 Investor presentation, January 2022 ...
The Investment Banking Off-cycle Internship is an opportunity to experience the culture and atmosphere in the Investment Banking Division (IBD) by taking on some of the responsibilities and functions of a Full-time Analyst for a short period. The internship typically lasts three to six months, but can vary in length depending on business needs ...